Age-dependent accumulation of advanced glycation end-products in adult Drosophila melanogaster

Mechanisms of Ageing and Development

Volumn 100, Issue 3, 1998, Pages 221-229

  Oudes, A J ^a   Herr, C M ^a   Olsen, Y ^a   Fleming, J E ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Advanced glycation end products; Ageing; Aminoguanidine HCl; Drosophila melanogaster

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; COLLAGEN; CRYSTALLIN; PROTEIN; SUGAR; UNCLASSIFIED DRUG;

ARTICLE; BIOACCUMULATION; BIOLOGY; CONTROLLED STUDY; DIABETES MELLITUS; DROSOPHILA MELANOGASTER; GLYCATION; LIFESPAN; NONHUMAN; PATHOLOGY; PRIORITY JOURNAL; TEMPERATURE;

AGING; ANIMALS; DROSOPHILA MELANOGASTER; GLYCOSYLATION END PRODUCTS, ADVANCED; GUANIDINES; LONGEVITY; MALE;

EID: 0032536461     PISSN: 00476374     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0047-6374(97)00146-2     Document Type: Article

References (22)

1. Ayres W., Small E., Isenberg I. A computerized fluorescence anisotrophy spectrometer. Ann. Biochem. 58:1974;361-367.
2. Beisswenger P.J., Makita Z., Curphey T.J., Moore L.L., Jean S., Brinck-Johnson T., Bacala R., Vlassara H. Formation of immunochemical advanced glycosylation end products precedes and correlates with the early manifestations of renal and retinal disease in diabetes. Diabetes. 44:1995;824-829.
3. Bliesener R., Lechner B., Deppisch R., Ritz E., Gerbitz K.D. Immunological determination of advanced glycation end products in human blood and urine. Nephrol. Dial. Transplant. 10:1995;644-657.
4. Booth A., Khalifah R., Hudson B. Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine. Biochem. Biophys. Res. Commun. 220:1996;113-119.
5. Brownlee M., Vlassara H., Kooney A., Ulrich P., Cerami A. Amioguanidine prevents diabetes-induced arterial wall protein cross-linking. Science. 232:1986;1629-1632.
6. Brownlee M., Cerami A., Vlassara H. Advanced glycosylation endproducts in tissue and the biochemical basis of diabetic complications. New Engl. J. Med. 318:1988;1315-1321.
7. Chibber R., Molinatti P., Wong J., Mirlees D., Kohner E. The effect of aminoguanidine and tolrestat on glucose toxicity in bovine retinal capillry pericytes. Diabetes. 43:1994;758-763.
8. Edelstein D., Brownlee M. Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidne. Diabetes. 41:1992;26-29.
9. Fleming, J.E., Rose, M.R., 1996. Genetics of aging in Drosophila. In: Schneider, E.L., Rowe, J.W. (Eds.), Handbook of the Biology of Aging. Academic Press, San Diego, CA, USA, pp. 74-93.
10. Fleming J.E., Quattrocki E., Latter G., Miquel S., Marcuson R., Zuckerkandl E., Bensch K.G. Age dependent changes in proteins of Drosophila melanogaster. Science. 231:1986;1157-1159.
11. Hammes H., Brownlee M., Edelstein D., Saleck M., Martin S., Federlin K. Aminoguanidine inhibits the developement of accelerated diabetic retinopathy in the spontaneous hypersensitive rat. Diabetologia. 37:1994;32-35.
12. Hirsch J., Petrakova E., Feather M., Barnes C. The reaction of D-glucose with aminoguanodine. Carbohydr. Res. 267:1995;17-25.
13. Li J.J., Surini M., Catsicas S., Kawashima E., Bouras C. Age-dependent accumulation of advanced glycation end products in human neurons. Neurobiol. Aging. 1:1995;69-76.
14. Li Y., Steffes M., Donnelly T., Liu C., Fuh H., Basgen J., Bucala R., Vlassara H. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine. Proc. Natl. Acad. Sci. USA. 93:1996;3902-3907.
15. Miquel J., Economos A.C., Bensch K.G. Insect versus mammalian aging. Aging Cell Struct. 1:1981;347-379.
16. Monnier V., Cerami A. Nonenzymatic browning in vivo: Possible process for aging of long-lived proteins. Science. 211:1981;491-493.
17. Nishino T., Horii Y., Shiiki H., Yamamoto H., Makita Z., Bucala R., Dohi K. Immunohistochemical detection of advanced glycation end products within the vascular lesions and glomeruli in diabetic nephropathy. Hum. Pathol. 26:1995;308-313.
18. 2-(1-carboxyethyl) guanine (CEG) as a guanine advanced glycosylation end product. Biochemistry. 34:1995;648-655.
19. Reveillaud I., Niedzwiecki A., Bensch K.G., Fleming J.E. Expression of bovine superoxide dismutase in Drosophila melanogaster augments resistance to oxidative stress. Mol. Cell. Biol. 11:1991;632-640.
20. Sugiyama T., Shimada H., Nomura M., Miyamoto K. Aminoguanidine inhibits cell proliferation by elongation of the mitotic phase. Toxicol. Lett. 69:1993;273-278.
21. Yan S.D., Yan S.F., Chen X., Fu J., Chen M., Kuppusamy P., Smith M.A., Perry G., Goodman G.C., Nawroth P., Zweier J.L., Stern D. Non enzymatically glycated tau in alzheimers disease induces neuronal antioxidant stress resulting in cytokine gene expression and release of amyloid beta-peptide. Nat. Med. 1:1995;693-699.
22. Yang C.-W., Vlassara H., Striker G.E., Striker L.J. Administration of AGEs in vivo induces genes implicated in diabetic glomerulosclerosis. Kidney Int. 47:1995;S55-58.